C5 complement inhibition versus FcRn modulation in generalised myasthenia gravis.
Huntemann N, Gerischer L, Herdick M, Nelke C, Stascheit F, Hoffmann S, Öztürk M, Schroeter CB, Lehnerer S, Stein M, Schubert C, Schneider-Gold C, Pfeuffer S, Krämer HH, Konen FF, Skripuletz T, Pawlitzki M, Glaubitz S, Zschüntzsch J, Scherwietes V, Totzeck A, Hagenacker T, Meuth SG, Meisel A, Ruck T.
Huntemann N, et al. Among authors: ozturk m.
J Neurol Neurosurg Psychiatry. 2025 Jan 11:jnnp-2024-334404. doi: 10.1136/jnnp-2024-334404. Online ahead of print.
J Neurol Neurosurg Psychiatry. 2025.
PMID: 39798960